Literature DB >> 17367585

Neuroendocrine implications of opioid therapy.

B Eliot Cole1.   

Abstract

Opioid analgesics are given to people with pain. These medications are highly effective for relieving pain and are generally considered to have little or no end-organ toxi-cities. Although they are generally feared because of their potential for abuse, diversion, and psychological dependence, little attention is given to their neuroendocrine consequences. They are known to have central nervous systems effects and are now understood to impact the regulation of gonadotropic hormones. Providing meaningful informed consent requires disclosure about the risks associated with lowered gonadotropic hormone levels.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17367585     DOI: 10.1007/s11916-007-0003-0

Source DB:  PubMed          Journal:  Curr Pain Headache Rep        ISSN: 1534-3081


  9 in total

Review 1.  Male factor infertility: evaluation and management.

Authors:  Victor M Brugh; Larry I Lipshultz
Journal:  Med Clin North Am       Date:  2004-03       Impact factor: 5.456

Review 2.  Andropause: a quality-of-life issue in older males.

Authors:  Matthew T Haren; Moon Jong Kim; Syed H Tariq; Gary A Wittert; John E Morley
Journal:  Med Clin North Am       Date:  2006-09       Impact factor: 5.456

Review 3.  Narcotic-induced hypogonadism during therapy for heroin addiction.

Authors:  Harry W Daniell
Journal:  J Addict Dis       Date:  2002

Review 4.  Incidence and prevalence of the sexual dysfunctions: a critical review of the empirical literature.

Authors:  I P Spector; M P Carey
Journal:  Arch Sex Behav       Date:  1990-08

5.  Endocrine consequences of long-term intrathecal administration of opioids.

Authors:  R Abs; J Verhelst; J Maeyaert; J P Van Buyten; F Opsomer; H Adriaensen; J Verlooy; T Van Havenbergh; M Smet; K Van Acker
Journal:  J Clin Endocrinol Metab       Date:  2000-06       Impact factor: 5.958

6.  Sex hormone suppression by intrathecal opioids: a prospective study.

Authors:  Lindy J Roberts; Phillip M Finch; Peter T Pullan; Chotoo I Bhagat; Leanne M Price
Journal:  Clin J Pain       Date:  2002 May-Jun       Impact factor: 3.442

7.  Hypogonadism in patients treated with intrathecal morphine.

Authors:  P M Finch; L J Roberts; L Price; N C Hadlow; P T Pullan
Journal:  Clin J Pain       Date:  2000-09       Impact factor: 3.442

8.  DHEAS deficiency during consumption of sustained-action prescribed opioids: evidence for opioid-induced inhibition of adrenal androgen production.

Authors:  Harry W Daniell
Journal:  J Pain       Date:  2006-12       Impact factor: 5.820

9.  Hypogonadism and sexual dysfunction in male cancer survivors receiving chronic opioid therapy.

Authors:  Arun Rajagopal; Rena Vassilopoulou-Sellin; J Lynn Palmer; Guddi Kaur; Eduardo Bruera
Journal:  J Pain Symptom Manage       Date:  2003-11       Impact factor: 3.612

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.